Active ingredientTopotecanCat. No. P-T164-001CAS 123948-87-8Family · Pharmaceutical analytical standards
Topotecan
A semi-synthetic, water-soluble anticancer drug derived from camptothecin, developed in the 1980s at the University of Florida and approved in the United States in 1996: it is used for ovarian cancer and small-cell lung cancer. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The camptothecin it comes from is found in the bark of Camptotheca acuminata, a Chinese tree called xi shu, 'happy tree': the plant's anticancer properties were discovered in 1958.
Go to the active ingredient →Active ingredientTopotecanCat. No. P-T164-001CAS 123948-87-8
Active ingredientTopotecan HydrochlorideCat. No. P-T164-002CAS 119413-54-6
Isotopically labelledTopotecan-d6Cat. No. P-T164-003CAS 1044904-10-0
Isotopically labelledTopotecan-d6 DiHClCat. No. P-T164-004
Impurity(R)-TopotecanCat. No. P-T164-005CAS 1797985-73-9
Impurity(R)-Topotecan DiHClCat. No. P-T164-006
ImpurityN-Desmethyl TopotecanCat. No. P-T164-007CAS 190710-79-3
ImpurityTopotecan Bis N-OxideCat. No. P-T164-008
ImpurityTopotecan Carboxylic Acid Sodium SaltCat. No. P-T164-009CAS 123949-08-6
ImpurityTopotecan N-OxideCat. No. P-T164-010CAS 1398723-05-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.